Jim Tananbaum, CEO and founder of Foresite Capital (a healthcare growth equity firm), recently welcomed the newest venture partner of the firm. The firm announced that Molly He, Ph.D., would be the next addition to their venture partnership. She brings 15 solid years of pharmaceutical and genomic research and developmental experience to Foresite Capital and is the former senior director at Illumina, an American company incorporated in April 1998 that develops, manufactures and markets integrated systems for the analysis of genetic variation and biological function. As per Bloomberg, Tananbaum states that “With her extensive expertise in genomics and drug development and her remarkable track record of leadership, she will be an invaluable resource to Foresite as we continue to expand and diversify our portfolio of transformational companies.” Dr. He finished her schooling with a Bachelor’s degree in biochemistry from Nankai University and a Ph.D. in protein biophysics from the University of California, Los Angeles. Not only is she well-accomplished academically, but also scholarly. She has authored over 20 published papers and is the owner of more than 20 patent issued patents and patent applications in the medicine and sequencing fields.
According to Businesswire, Jim Tananbaum is a well-versed CEO and has over 25 years of experience in his industry. And as Forbes states, “Earlier in his career, he has been part of Prospect Venture Partners II and III and Sierra Ventures. His major investments included Amira Pharmaceuticals, Amerigroup, Healtheon, and Jazz Pharmaceuticals. He holds a BS and a B.S.E.E. from Yale University, an MD from Harvard Medical School, an MS from MIT and an MBA from Harvard Business School.”
Throughout his illustrious career, he has been a part of building multiple healthcare franchises and even sold GelTex Pharmaceuticals (of which he was also the founder) for 1.6 billion dollars. Currently, the sales of Renzel (GelTex’s highest selling drug), brings in a revenue stream of around 1 billion dollars annually. Interestingly enough, Mr. Tananbaum started this company while still in college at Harvard University. More details can be found on Insidermonkey.com